99 related articles for article (PubMed ID: 16879394)
41. [Clinical significance and expression of vascular endothelial growth factor in serum of patients with acute leukemia].
Xie JM; Qi ZH
Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):183-5. PubMed ID: 12934374
[TBL] [Abstract][Full Text] [Related]
42. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
43. [Preliminary study of VEGF and its receptor expression on childhood acute lymphoblastic leukemia and its relativity to clinical manifestations].
Liang AB; Li L; Xie XT; Jiang H; Ye H; Zhao JC; Gu LJ
Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):489-92. PubMed ID: 16383242
[TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor in chronic rat allograft nephropathy.
Malmström NK; Kallio EA; Rintala JM; Nykänen AI; Räisänen-Sokolowski AK; Paavonen T; Lemström KB; Koskinen PK
Transpl Immunol; 2008 May; 19(2):136-44. PubMed ID: 18503889
[TBL] [Abstract][Full Text] [Related]
45. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL).
Demacq C; Vasconcellos VB; Izidoro-Toledo TC; da Silva Silveira V; Canalle R; Queiroz RG; Tone LG; Tanus-Santos JE
Clin Chim Acta; 2010 Sep; 411(17-18):1335-40. PubMed ID: 20510681
[TBL] [Abstract][Full Text] [Related]
46. Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia.
Shin YJ; Choi JS; Lee JY; Choi JY; Cha JH; Chun MH; Lee MY
Acta Neuropathol; 2008 Nov; 116(5):517-27. PubMed ID: 18704465
[TBL] [Abstract][Full Text] [Related]
47. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects.
Yang XH; Man XY; Cai SQ; Yao YG; Bu ZY; Zheng M
Biochem Biophys Res Commun; 2006 Oct; 349(1):31-8. PubMed ID: 16930552
[TBL] [Abstract][Full Text] [Related]
48. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.
Detoraki A; Staiano RI; Granata F; Giannattasio G; Prevete N; de Paulis A; Ribatti D; Genovese A; Triggiani M; Marone G
J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959
[TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
[TBL] [Abstract][Full Text] [Related]
51. The comparison of VEGFR-1-binding domain of VEGF-A with modelled VEGF-C sheds light on receptor specificity.
Kasap M; Sazci A
J Theor Biol; 2008 Aug; 253(3):446-51. PubMed ID: 18479712
[TBL] [Abstract][Full Text] [Related]
52. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
Yano A; Fujii Y; Iwai A; Kawakami S; Kageyama Y; Kihara K
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6012-7. PubMed ID: 17062674
[TBL] [Abstract][Full Text] [Related]
53. Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.
Gretschel S; Astrosini Ch; Vieth M; Jöns T; Tomov T; Höcker M; Schlag PM; Kemmner W
Eur J Surg Oncol; 2008 Jun; 34(6):642-7. PubMed ID: 18023552
[TBL] [Abstract][Full Text] [Related]
54. Expression and cellular localization of vascular endothelial growth factor A and its receptors in acute and chronic leukemias: an immunohistochemical study.
Zhang Y; Pillai G; Gatter K; Blázquez C; Turley H; Pezzella F; Watt SM
Hum Pathol; 2005 Jul; 36(7):797-805. PubMed ID: 16084950
[TBL] [Abstract][Full Text] [Related]
55. The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy.
Mao K; Badoual C; Camparo P; Delongchamps NB; Vieillefond A; Dinh-Xuan AT; Peyromaure M
Can J Urol; 2008 Oct; 15(5):4257-62. PubMed ID: 18814815
[TBL] [Abstract][Full Text] [Related]
56. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.
Norén-Nyström U; Heyman M; Frisk P; Golovleva I; Sundström C; Porwit A; Roos G; Bergh A; Forestier E
Br J Haematol; 2009 Sep; 146(5):521-30. PubMed ID: 19594745
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of vascular endothelial growth factors and their receptors in multiple myeloma.
Kimlinger T; Kline M; Kumar S; Lust J; Witzig T; Rajkumar SV
Haematologica; 2006 Aug; 91(8):1033-40. PubMed ID: 16870555
[TBL] [Abstract][Full Text] [Related]
58. [Plasma levels of VEGF-C, VEGF-D, VEGFR-2 and VEGFR-3 in patients with newly diagnosed lymphomas].
Liu F; Song YQ; Zhang C; Fu ZY; Ping LY; Ying ZT; Zheng W; Wang XP; Xie Y; Lin NJ; Tu MF; Zhu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1184-8. PubMed ID: 22040968
[TBL] [Abstract][Full Text] [Related]
59. Vascular endothelial growth factor (VEGF)-C - a potent risk factor in children diagnosed with stadium 4 neuroblastoma.
Nowicki M; Konwerska A; Ostalska-Nowicka D; Derwich K; Miskowiak B; Kondraciuk B; Samulak D; Witt M
Folia Histochem Cytobiol; 2008; 46(4):493-9. PubMed ID: 19141404
[TBL] [Abstract][Full Text] [Related]
60. Vascular endothelial growth factor (VEGF-C1)-dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach.
Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwinska A; Witt M
Histopathology; 2005 Feb; 46(2):176-83. PubMed ID: 15693890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
